Inventor · disambiguated record
Ivan William Hemeon
Also filed as: HEMEON IVAN · HEMEON IVAN WILLIAM
17 granted patents·10 pending applications·129 citations·filing 2011–2021
93Inventor score
Top patents by PatentIndex Score
27 records- 0197US8933236B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Jan 13, 2015·50 cites·32 claims
- 0295US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0392US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 0492US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 0591US9771376B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 26, 2017·7 cites·19 claims
- 0687US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 0783US9550775B2Substituted triazolopyridines and methods of use thereofGENENTECH INC·Filed 2014·Granted Jan 24, 2017·7 cites·26 claims
- 0882US10766858B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2017·Granted Sep 8, 2020·1 cites·19 claims
- 0982US9487535B2Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Nov 8, 2016·5 cites·26 claims
- 1081US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 1176US11130726B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·20 claims
- 1276US10526285B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 7, 2020·1 cites·17 claims
- 1375US2022055977A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1470US11149002B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 19, 2021·0 cites·13 claims
- 1570US10071957B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Sep 11, 2018·1 cites·2 claims
- 1669US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1767US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1867US2018230079A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 1964US2015224071A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 2060US11203572B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2020·Granted Dec 21, 2021·0 cites·20 claims
- 2158US2021253548A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2256US2017002017A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 2351US2018346416A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2446US2017066777A1Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2545US10899732B2Substituted benzamides useful as sodium channel blockersGENENTECH INC·Filed 2016·Granted Jan 26, 2021·0 cites·17 claims
- 2644US2013004947A1Luciferase-linked analysis of dna-methyltransferase, protein methyltransferase and s-adenosylhomocysteine and uses thereofSCHRAMM VERN L·Filed 2011·Application pending·0 cites
- 2740US10179767B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jan 15, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Ivan William Hemeon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →